Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
International Journal of Clinical Practice|May 24, 2019
Factors associated with medication adherence in a longitudinal study of rheumatoid arthritis patientsNasir Wabe, Anita Lee, Mihir Wechalekar, et al.
Rheumatology International|February 5, 2017
Adherence to combination DMARD therapy and treatment outcomes in rheumatoid arthritis: a longitudinal study of new and existing DMARD usersNasir Wabe, Anita Lee, Mihir Wechalekar, et al.
Journal of Scleroderma and Related Disorders|October 11, 2024
Views of nutrition needs in patients with systemic sclerosisDe-Arne Samm, Aimee Macoustra, Rhiannon Crane, et al.
Seminars in Arthritis and Rheumatism|June 29, 2019
The neutrophil-lymphocyte ratio in early rheumatoid arthritis and its ability to predict subsequent failure of triple therapyDaniel Boulos, Susanna M Proudman, Robert G Metcalf, et al.
Internal Medicine Journal|June 4, 2019
Scleroderma in Cairns: an epidemiological studySamuel Abbot, Leah McWilliams, Llewellyn Spargo, et al.
Clinical Endocrinology|April 11, 2016
Reduced corticosteroid-binding globulin cleavage in active rheumatoid arthritisMarni A Nenke, John G Lewis, Wayne Rankin, et al.
International Journal of Rheumatic Diseases|September 28, 2017
Disease activity trajectories in early rheumatoid arthritis following intensive DMARD therapy over 3 years: association with persistence to therapyNasir Wabe, Jessica Wojciechowski, Mihir D Wechalekar, et al.
BMC Rheumatology|November 15, 2022
Using the derived 28-joint disease activity score patient-reported components (DAS28-P) index as a discriminatory measure of response to disease-modifying anti-rheumatic drug therapy in early rheumatoid arthritisHuai Leng Pisaniello, Samuel L Whittle, Susan Lester, et al.
The Journal of Rheumatology|February 15, 2026
The impact of area-level socioeconomic status on disease outcomes in rheumatoid arthritis: results from an Australian longitudinal inception cohort studyOscar Russell, Susan Lester, Jessica Stanhope, et al.
Patient Education and Counseling|December 4, 2025
Patients' attitudes towards deprescribing disease modifying anti-rheumatic drugs in rheumatoid arthritisLauren Fraser, Michael D Wiese, Nagham Ailabouni, et al.
Pageof 2